The "Gastrointestinal Diagnostics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Gastrointestinal Diagnostics was valued at US$4.9 ...

The "Constipation Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Constipation Treatment was valued at US$19.5 Billion in 2024 ...

Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. (“PRISM”) to accelerate the discovery and ...

The "Drug Discount Cards Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Drug Discount Cards was valued at US$14.9 Billion in 2024 ...

RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world’s leading pharmaceutical manufacturers, today announced the ...

Ideagen achieved a market-leading score (3.0/3.0) for AI Operations in the Verdantix Green Quadrant for Quality Management ...

DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, today announced it has secured $3.5 million in funding from a prominent, family office. This significant investment solidifies the ...

Agreements Advance Biocerta’s Functional Precision Oncology Platform, Aiming to Deliver the Right Treatment, First Time, ...

Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research ...

First-of-its-kind hospitality partnership brings biotech-backed ‘social wellness’ to one of the world’s premier après destination resortsSAN FRANCISCO--(BUSINESS WIRE)--ZBiotics®, the world's first ...

MODAG GmbH announced it has received a $1 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding is part of MJFF’s strategic research agenda focused on ...

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared to placeboFavorable safety and tolerability data were ...